Archimedic
Generated 5/9/2026
Executive Summary
Archimedic is a US-based MedTech design firm that provides integrated design, regulatory, and go-to-market services to medical device innovators. Founded in 2013 and headquartered in Providence, Rhode Island, the company operates as a contract development organization (CDO) guiding clients from concept to commercialization. Its expertise spans surgical, drug delivery, diagnostic, and home health categories. As a private company focused on service revenue, Archimedic's growth is tied to the success of its clients' devices and the broader MedTech innovation ecosystem. With no disclosed funding or valuation, the firm demonstrates stable operations in the contract development space, benefiting from the trend of outsourced R&D by larger medical device companies.
Upcoming Catalysts (preview)
- Q3 2025Announcement of Major Client Partnership or Program Win65% success
- Q4 2025FDA 510(k) Clearance for Client Device Developed with Archimedic50% success
- Q1 2026Expansion into New Therapeutic Category or Service Offering40% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)